NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bavarian Nordic A/S (CO: BAVA)

BAVA Technical Analysis
As on 2nd Apr 2024 BAVA STOCK Price closed @ 162.50 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 157.95 Change Price %
High 162.50 1 Day N/A N/A
Low 157.90 1 Week 0.00 0.00
Close 162.50 1 Month 0.00 0.00
Volume 741344 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
CO Denmark Most Active Stocks
SAS 0.01 %
SAS-DKK 0.02 %
NOVO-B 867.10 %
VWS 186.20 %
ALMB 13.01 %
BIF 0.72 %
BIOPOR 1.36 %
DANSKE 207.30 %
TRYG 144.20 %
AMBU-B 111.35 %
CO Denmark Top Gainers Stocks
DKIEEU 249.00 15.81%
SYILATKL 237.20 3.40%
CWIGAAKKKL 200.80 3.03%
CWIASKL 243.70 2.65%
JYIKIKL 82.00 2.50%
CWIGAEKL 152.45 2.45%
CWIGAKL 1010.60 2.37%
AOJ-P 88.00 2.33%
CWISAKTKL 177.60 1.92%
NZYM-B 323.50 1.67%
CO Denmark Top Losers Stocks
BLVIS-A 0.40 -18.37%
VIPRO 0.88 -4.35%
SEIJHP 103.85 -3.53%
LSIDKA 121.13 -3.29%
SYVAAA 147.59 -2.68%
AUDNTS 5.50 -2.48%
HAINOR 106.06 -2.16%
SYVVUA 100.70 -2.14%
SYIVLVADKKA 162.76 -2.10%
SEIBVP 195.40 -2.03%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
BAVA Important Levels Intraday
BAVA Forecast June 2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
BAVA Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
BAVA Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
BAVA Other Details
Segment EQ
Market Capital 19401670656.00
Sector Healthcare
Industry Biotechnology
Offical website >
BAVA Address
BAVA Latest News
Your Comments and Response on Bavarian Nordic A/S
BAVA Business Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; monkeypox under the JYNNEOS name; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that is in Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase II clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that is in Phase I/II clinical trial for the treatment of SARS-CoV-2; TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2- and brachyury-expressing cancers; and MVA-BN WEV that is in Phase I clinical trial for treating Equine encephalitis.It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, Canada, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is based in Hellerup, Denmark. Address: Philip Heymans Alle 3, Hellerup, Denmark, 2900
2005-2023 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service